About
Raphael Townshend is the founder and CEO of Atomic AI, where he oversees the development of AI technologies for synthetic biology and drug discovery, focusing on RNA modeling to accelerate therapeutic innovations. He earned a PhD in Computer Science from Stanford University, with expertise in machine learning applications to biological problems. Townshend has contributed to the field through research on AI-driven protein and RNA design, including publications in top journals. His achievements include founding Atomic AI in 2021 and securing significant venture funding for the company's biotech initiatives. His primary expertise areas are AI, machine learning, and computational biology.
